Hyperglycemia and acute illness;Hyperglycémie et pathologies aiguës

Annales d'Endocrinologie

Volumn 67, Issue 3, 2006, Pages 224-232

  Jeandidier, N ^a   Boullu Sanchis, S ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

Intensive insulin therapy; IV insulin therapy; Mortality during hospitalization; Stress hyperglycemia

Indexed keywords

C REACTIVE PROTEIN; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; ORAL ANTIDIABETIC AGENT;

AGGRESSION; CHEMOTAXIS; CLINICAL PRACTICE; CLINICAL PROTOCOL; COMPLEMENT FACTOR; CRITICAL ILLNESS; HUMAN; HYPERGLYCEMIA; IMMUNE SYSTEM; INFLAMMATION; INSULIN TREATMENT; INTENSIVE CARE UNIT; MORBIDITY; MORTALITY; MULTINUCLEAR CELL; PHAGOCYTOSIS; REVIEW; STATISTICAL SIGNIFICANCE;

EID: 33745653879     PISSN: 00034266     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4266(06)72590-2     Document Type: Article

References (27)

1. Boullu-Sanchis S, Ortega F, Chabrier G et al. Efficacy of short term subcutaneous insulin lispro versus continuous regular insulin in poorly controlled hospitalized type 2 diabetic patients. Diabetes Metab (sous presse).
2. Cao J, Hudson M, Jankowski M, Whitehouse F, Weaver W. Relation of chronic and acute glycemic control on mortality in acute myocardial infarction with diabetes mellitus. Am J Cardiol 2005 ; 96 : 183-6.
3. Clement S, Braithwaite S, Ahman A et al. Management of diabetes and hyperglycemia in Hospitals. Diabetes care 2004 ; 27 : 553-91.
4. Conner TM, Flesner-Gurley KR, Barner JC. Hyperglycemia in the hospital setting: the case for improved control among non-diabetics. Ann Pharmacother 2005 ; 39 : 492-501.
5. Dandona P, Mohanty P, Chaudhuri A, Garg R, Aljada A. Insulin infusion in acute illness. J Clin Invest 2005 ; 115 : 2069-72.
6. Diez Tejedor E, Fuentes B. Acute care in stroke: the importance of early intervention to achieve better brain protection. Cerebrovasc Dis 2004 ; 17 : S130-7.
7. Fink-Mitchell P. Research: advances in cell biology relevant to critical illness. Curr Opin Crit Care 2004 ; 10 : 279-91.
8. Gabay C, Kushner I. Acute phase proteins and other systemic response to inflammation. New Engl J Med 1999 ; 11 : 448-54.
9. Goldsberg P, Sakharova O, Barett P et al. Improving glycemic control in the cardiothoracic intensive care unit: clinical experience in two hospital settings. J Cardiothoracic and vascular anesthesia, 2004 ; 18 : 690-7.
10. Hansen T, Thiel S, Wouters P, Sandahl J, Van den Berghe G. Intensive Insulin therapy exerts Anti-inflammatory Effects in Critically III Patients and Counteracts the Effects of Low Mannose - Binding Lectin Levels. J Clin Endocrinol Metab 2003 ; 88 : 1082-8.
11. Inzucchi S, Rosenstock J. Counterpoint: in-patient glucose management; a premature call to arms. Diabetes Care 2005 ; 28 : 976-97.
12. Langouche L, Vanhorebeek I, Vlasselaers D et al. Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest 2005 ; 115 : 2277-86.
13. Malmberg K, Norhammar A, Wedel H, Ryden H. DIGAMI study. Circulation 1999 ; 96 : 2626-32.
14. Malmberg K, Ryden L, Wedel H. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI2): effects on mortality and morbidity. Eur Heart J 2005 ; 26 : 650-61.
15. Marik P, Raghavan M. Stress-hyperglycemia, insulin and immunomodulation in sepsis. Intensive Care in Medicine 2004 ; 30 : 748-56.
16. Mc Allster Fa, Majumdar SR, Blitz S et al. The relation between hyperglycemia and outcomes in 2 471 patients admitted to the hospital with community - acquired pneumonia. Diabetes Care 2005 ; 28 : 810-5.
17. Mesotten D, Swinnen J, Vanderhoydonc F et al. Contribution of circulating lipids to the improved outcome of critical illness by glycemic control with intensive insulin therapy. J Clin Endocrinol Metab 2004; 89: 219-26.
18. Moghissi EE, Hirsch I. Hospital Management of Diabetes. Endocrinol Metab Clin N Am 2005 ; 34 : 99-116.
19. Pittas A, Siegel R, Lau J. Insulin therapy for Critically Ill Hospitalized Patients. A meta-analysis of randomized Controlled Trials. Arch Intern Med 2004 ; 164 : 2005-11.
20. The CREATE-ECLA Trial Group Investigators. Effect of glucose - insulin - potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction. JAMA 2005 ; 293 : 437-46.
21. Turina M, Fry D, Polk H. Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects. Crit Care Med 2005 ; 33 : 1624-33.
22. Umpierrez G, Isaacs S, Bazargan N, You X, Thaler L, Kitbachi A. Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002 ; 87 : 978-2.
23. Umpierrez GE, Latif K, Stoever J et al. Efficacy of Subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis. Am J Med 2004 ; 117 : 291-6.
24. Van den Berghe G, Wouters P, Weekers F et al. Intensive insulin therapy in critically ill patients. N Engl J Med 2001 ; 345 : 1359-67.
25. Van den Berghe G, Wouters P, Bouillon R et al. Outcome benefits of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med 2003 ; 31 : 359-66.
26. Van den Berghe G. How does blood glucose control with insulin save lives in intensive care? J Clin Invest 2004 ; 114 : 1187-95.
27. Vanhoreek I, Langouche L, Van den Berghe G. Glycemic and nonglycemic effects of insulin: how do they contribute to a better outcome of critical illness? Curr Opin Crit Care 2005 ; 11 : 304-11.